!A complainant to the Ombudsman alleged, inter alia, lack of transparency and undue delay by the European Medicines Agency (EMEA) in response to concerns she had raised with it about an antidepressant’s safety and suicide risk.
Líomhain gearánach don Ombudsman, inter alia, easpa trédhearcachta agus moill inseachanta ón nGníomhaireacht Eorpach Leigheasra (EMEA) mar fhreagairt ar imní a bhí ardaithe leis an nGníomhaireacht maidir le sábháilteacht frithdhúlagráin agus baol féinmharaithe.